Codelivery of DOX and siRNA by folate-biotin-quaternized starch nanoparticles for promoting synergistic suppression of human lung cancer cells

References

• Ahmadzada T, Reid G, McKenzie DR. (2018). Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer. Biophy rev 10:69–86.
   PubMedGoogle Scholar
• Bica-Pop C, Cojocneanu-Petric R, Magdo L, et al. (2018). Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci 75:3539–51.
   PubMed Web of Science ®Google Scholar
• Chen L, Ji F, Bao Y, et al. (2017). Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. Mater Sci Eng C 70:418–29.
   PubMed Web of Science ®Google Scholar
• Chen K, Zhang S, Wang H, et al. (2019). Fabrication of doxorubicin–loaded glycyrrhetinic acid–biotin–starch nanoparticles and drug delivery into HepG2 cells in vitro. Starch–Stärke 71:1800031.
   Google Scholar
• Chulpanova DS, Solovyeva VV, Kitaeva KV, et al. (2018). Recombinant viruses for cancer therapy. Biomedicines 6:94.
   Web of Science ®Google Scholar
• Collett GK, Durcinoska I, Rankin NM, et al. (2019). Patients’ experience of lung cancer care coordination: a quantitative exploration. Support Care Cancer 27:485–93.
   Google Scholar
• Dai X, Tan C. (2015). Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers. Adv Drug Deliv Rev 81:184–97.
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Qiu X, Winnik FM, et al. (2012). Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies. Int J Nanomed 7:5833–45.
   PubMed Web of Science ®Google Scholar
• Gao Y, Wang Z-Y, Zhang J, et al. (2014). RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain. Biomacromolecules 15:1010–8.
   PubMed Web of Science ®Google Scholar
• Guzman-Villanueva D, El-Sherbiny IM, Vlassov AV, et al. (2014). Enhanced cellular uptake and gene silencing activity of siRNA molecules mediated by chitosan-derivative nanocomplexes. Int J Pharm 473:579–90.
   PubMed Web of Science ®Google Scholar
• Hague C, Foran B, Hall E, et al. (2018). Patient involvement in the design of a phase III trial comparing intensity-modulated proton therapy and intensity-modulated radiotherapy for oropharyngeal cancer. Clin Oncol 30:274–6.
   Web of Science ®Google Scholar
• Hilmi C, Larribere L, Giuliano S, et al. (2008). IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin. J Invest Dermatol 128:1499–505.
   PubMed Web of Science ®Google Scholar
• Hou H, Zhang D, Lin J, et al. (2018). Zein-paclitaxel prodrug nanoparticles for redox-triggered drug delivery and enhanced therapeutic efficiency. J Agric Food Chem 66:11812–22.
   PubMed Web of Science ®Google Scholar
• Hu L, Pang S, Hu Q, et al. (2015). Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin. Biomed Pharmacother 75:26–32.
   PubMed Web of Science ®Google Scholar
• Hu Q-D, Tang G-P, Chu PK. (2014). Cyclodextrin-based host-guest supramolecular nanoparticles for delivery: from design to applications. Acc Chem Res 47:2017–25.
   PubMed Web of Science ®Google Scholar
• Hussein EA, Zagho MM, Nasrallah GK, Elzatahry AA. (2018). Recent advances in functional nanostructures as cancer photothermal therapy. Int J Nanomed 13:2897–906.
   Web of Science ®Google Scholar
• Jones HE, Goddard L, Gee JMW, et al. (2004). Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocr Relat Cancer 11:793–814.
   PubMed Web of Science ®Google Scholar
• Kato T, Jin CS, Ujiie H, et al. (2017). Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer. Lung Cancer 113:59–68.
   PubMed Web of Science ®Google Scholar
• Kuhn DA, Vanhecke D, Michen B, et al. (2014). Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J Nanotechnol 5:1625–36.
   PubMed Web of Science ®Google Scholar
• Li L, Tao R, Song M, et al. (2017). Fabrication of self-assembled folate-biotin-quaternized starch nanoparticles as co-carrier of doxorubicin and siRNA. J Biomater Appl 32:587–97.
   PubMed Web of Science ®Google Scholar
• Li N, Zhang Q, Jia Z, et al. (2018). Volatile oil from alpinia officinarum promotes lung cancer regression in vitro and in vivo. Food Funct 9:4998–5006.
   PubMed Web of Science ®Google Scholar
• Li S, Sun Z, Meng X, et al. (2018). Targeted methotrexate prodrug conjugated with heptamethine cyanine dye improving chemotherapy and monitoring itself activating by dual-modal imaging. Front Mater 5:35.
   Web of Science ®Google Scholar
• Ma W, Kang Y, Ning L, et al. (2017). Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway. Exp Ther Med 14:2853–62.
   PubMed Web of Science ®Google Scholar
• Massoumi B, Mozafari Z, Jaymand M. (2018). A starch-based stimuli-responsive magnetite nanohydrogel as de novo drug delivery system. Int J Biol Macromol 117:418–26.
   Web of Science ®Google Scholar
• Muthukumar T, Chamundeeswari M, Prabhavathi S, et al. (2014). Carbon nanoparticle from a natural source fabricated for folate receptor targeting, imaging and drug delivery application in A549 lung cancer cells. Eur J Pharm Biopharm 88:730–6.
   PubMed Web of Science ®Google Scholar
• Novo L, Takeda KM, Petteta T, et al. (2015). Targeted decationized polyplexes for siRNA delivery. Mol Pharm 12:150–61.
   PubMed Web of Science ®Google Scholar
• Nuhn L, Hirsch M, Krieg B, et al. (2012). Cationic nanohydrogel particles as potential siRNA carriers for cellular delivery. ACS Nano 6:2198–214.
   PubMed Web of Science ®Google Scholar
• Piras S, Carta A, Briguglio I, et al. (2014). 2-[N-Alkyl (R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes. Eur J Med Chem 75:169–83.
   PubMed Web of Science ®Google Scholar
• Salzano G, Riehle R, Navarro G, et al. (2014). Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer. Cancer Lett 343:224–31.
   PubMed Web of Science ®Google Scholar
• Singh RP, Sharma G, Sonali, et al. (2017). Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery. Mater Sci Eng C 77:446–58.
   Google Scholar
• Sun C-Y, Shen S, Xu C-F, et al. (2015). Tumor acidity-sensitive polymeric vector for active targeted siRNA delivery. J Am Chem Soc 137:15217–24.
   PubMed Web of Science ®Google Scholar
• Suo A, Qian J, Xu M, et al. (2017). Folate-decorated PEGylated triblock copolymer as a pH/reduction dual-responsive nanovehicle for targeted intracellular co-delivery of doxorubicin and Bcl-2 siRNA. Mater Sci Eng C 76:659–72.
   Google Scholar
• Suo A, Qian J, Zhang Y, et al. (2016). Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells. Mater Sci Eng C 62:564–73.
   PubMed Web of Science ®Google Scholar
• Tanino R, Tsubata Y, Harashima N, et al. (2018). Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer. Oncotarget 9:16807–21.
   Google Scholar
• Tekade RK, Tekade M, Kesharwani P, D'Emanuele A. (2016). RNAi-combined nano-chemotherapeutics to tackle resistant tumors. Drug Discov Today 21:1761–74.
   PubMed Web of Science ®Google Scholar
• Tian Y, Jiang X, Chen X, et al. (2014). Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant cancer. Adv Mater 26:7393–8.
   PubMed Web of Science ®Google Scholar
• Tsubaki M, Satou T, Itoh T, et al. (2012). Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells. Leuk Res 36:1315–22.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang M, Zheng M, et al. (2015). Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Colloids Surf B Biointerfaces 129:63–70.
   PubMed Web of Science ®Google Scholar
• Wang S, Xu Y, Chan HF, et al. (2016). Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy. J Control Rel 240:454–64.
   PubMed Web of Science ®Google Scholar
• Warshamana-Greene GS, Litz J, Buchdunger E, et al. (2005). The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin Cancer Res 11:1563–71.
   PubMed Web of Science ®Google Scholar
• Xia Y, Wang X, Cheng H, et al. (2017). A polycation coated liposome as efficient siRNA carrier to overcome multidrug resistance. Colloids Surf B Biointerfaces 159:427–36.
   PubMed Web of Science ®Google Scholar
• Xia Y, Zhao M, Chen Y, et al. (2018). Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy. RSC Adv 8:25932–40.
   PubMed Web of Science ®Google Scholar
• Zhang W, Sun J, Fang W, et al. (2015). Nanomicelles based on X-shaped four-armed peglyated distearylglycerol as long circulating system for doxorubicin delivery. Eur J Pharm Sci 66:96–106.
   PubMed Web of Science ®Google Scholar
• Zhao YN, Piao YZ, Zhang CM, et al. (2017). Replacement of quaternary ammonium headgroups by tri-ornithine in cationic lipids for the improvement of gene delivery in vitro and in vivo. J Mater Chem B 5:7963–73.
   Web of Science ®Google Scholar
• Zheng G, Shen Y, Zhao R, et al. (2017). Dual-targeting multifuntional mesoporous silica nanocarrier for codelivery of siRNA and ursolic acid to folate receptor overexpressing cancer cells. J Agric Food Chem 65:6904–11.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zhang Y, Chen D, et al. (2016). Monascus pigment rubropunctatin: a potential dual agent for cancer chemotherapy and phototherapy. J Agric Food Chem 64:2541–8.
   PubMed Web of Science ®Google Scholar
• Zhou J, Sun J, Chen H, Peng Q. (2018). Promoted delivery of salinomycin sodium to lung cancer cells by dual targeting PLGA hybrid nanoparticles. Int J Oncol 53:1289–300.
   PubMed Web of Science ®Google Scholar
• Zhu C, Jung S, Luo S, et al. (2010). Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials 31:2408–16.
   PubMed Web of Science ®Google Scholar